YDES
YD Bio Ltd
7.60$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
YD Bio Ltd (YDES) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 25), "Total Operating Expenses" came in at 0.4 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | LTM* |
|---|---|---|---|---|---|---|---|---|
| 0.5 | 1.0 | 0.5 | 0.3 | 0.4 | 0.4 | 0.4 | 1.4 | |
| -0.5 | -1.0 | -0.5 | -0.3 | -0.4 | -0.4 | -0.4 | -1.4 | |
| 0.7 | -22 | 17 | 2.2 | 0.4 | -3.4 | -2.2 | -3.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | – | |
| 0.7 | -22 | 17 | 2.2 | 0.4 | -3.4 | -2.2 | -3.0 | |
| 0.7 | -22 | 17 | 2.2 | 0.4 | -3.4 | -2.2 | -3.0 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.